PATH | VRL
Menu

Find resources

Total results with these characteristics: 1865

Page 92 of 94
What Do the Next 100 Years Hold for Pneumococcal Vaccination?

This editorial article, published in Expert Review of Vaccines, provides a brief historical overview of vaccination against pneumococcal disease and offers a perspective on the future of pneumococcal vaccines. The authors describe the …

Author: Rijkers GT, van Mens SP, van Velzen-Blad H

Publication date: 2010

What Information Do You Need to Drive Your Immunization Program?

This three-part banner illustrates how better access to information can help improve the performance of vaccination programs.

Author: PATH, World Health Organization

Publication date: 2013

What is the WHO Vaccine Safety Net?

This video provides information on the World Health Organization's Vaccine Safety Net (VSN), a global network of websites providing reliable, understandable, and evidence-based information on vaccine safety.

Author: VaccinesToday

Publication date: 2018

What Vaccine Product Attributes Do Immunization Program Stakeholders Value? Results From Interviews in Six Low- and Middle-Income Countries

This article, published in Vaccine, reports the results of a study that aimed to capture the opinions of stakeholders working in immunization programs in low- and middle-income countries in order to understand how vaccine products could be improved …

Author: Kristensen DD, Bartholomew K, Villadiego S, Lorenson K

Publication date: 2016

What Would Happen if We Stopped Vaccinations?

This web page provides a summary of disease-related consequences of stopping immunizations. Vaccination programs have eliminated or significantly reduced many vaccine-preventable diseases in the United States and elsewhere. However, these diseases …

Author: US Centers for Disease Control and Prevention

Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

Published in the journal Clinical Infectious Diseases, this study analyzed more than 70 recent data sets to compare the serogroups causing invasive pneumococcal disease with those represented in conjugate vaccine formulations. ABSTRACT ONLY. (Learn …

Author: Hausdorff WP, Bryant J, Paradiso P, Siber G

Publication date: 2000

White Paper – Rotavirus: Common, Severe, Devastating, Preventable

This white paper provides a comprehensive source of information on rotavirus disease and vaccines. The 50-page synthesis includes the latest evidence and programmatic information about: rotavirus disease burden; vaccines in global use, nationally …

Author: ROTA Council

Publication date: 2016

WHO Best Practices for Injections and Related Procedures Toolkit

This toolkit covers elements of standard precautions relevant to the transmission of bloodborne pathogens through unsafe injection practices in health-care settings. It aims to help to increase health workers’ awareness of the importance of …

Author: World Health Organization, Safe Injection Global Network

Publication date: 2010

WHO Brighton Collaboration on Maternal Immunization Meeting Report

This report summarizes a consultation meeting held jointly by the World Health Organization's Initiative for Vaccine Research and the Brighton Collaboration in Geneva, Switzerland, from July 24 to 25, 2014 to facilitate harmonization of key events …

Author: World Health Organization

Publication date: 2014

WHO Cervical Cancer Prevention and Control Costing (C4P) Tool User Guide

The World Health Organization has developed a generic costing and planning tool for cervical cancer prevention and control to help program planners and managers generate annual cost projections over a five-year period to scale-up human …

Author: World Health Organization

Publication date: 2012

WHO Consultation on ETEC and Shigella Burden of Disease, Geneva, 6–7th April 2017: Meeting Report

This article, published in Vaccine, outlines the key outcomes and recommendations that came out of a World Health Organization technical consultation on Enterotoxigenic Escherichia coli (ETEC) and Shigella. The meeting convened subject matter …

Author: Hosangadi D, Smith PG, Kaslow DC, Giersing BK, the WHO ETEC & Shigella Vaccine Consultation Expert Group

Publication date: 2018

WHO Consultation on Group B Streptococcus Vaccine Development: Report From a Meeting Held on 27-28 April 2016

This article, published in Vaccine, reports the outcome of a World Health Organization technical consultation that considered development pathways for group B Streptococcus (GBS) vaccines. The meeting discussed numerous topics, including disease …

Author: Kobayashi M, Schrag SJ, Alderson MR, et al.

Publication date: 2016

WHO Consultation on Respiratory Syncytial Virus Vaccine Development Report From a World Health Organization Meeting Held on 23–24 March 2015

This article, published in Vaccine, summarizes a World Health Organization-convened respiratory syncytial virus (RSV) vaccine consultation held on March 23 and 24, 2015 in Geneva, Switzerland, which brought together experts from around the world to …

Author: Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS, the WHO RSV Vaccine Consultation Expert Group

Publication date: 2015

WHO Expert Consultation on Serotype Composition of Pneumococcal Conjugate Vaccines for Use in Resource-Poor Developing Countries, 26–27 October 2006, Geneva.

Published in the journal Vaccine, this article reports on a World Health Organization expert consultation to formulate a data-driven approach to determine the minimum or optimal formulation of pneumococcal conjugate vaccines, particularly keeping in …

Author: Cherian T

Publication date: 2007

WHO Global Action Plan to Minimize Poliovirus Facility-Associated Risk After Type-Specific Eradication of Wild Polioviruses and Sequential Cessation of Oral Polio Vaccine Use

This is the third edition of the Global Action Plan for eradicating polio. It includes suggested guidelines for the safe handling and containment of poliovirus infectious and potentially infectious materials, with the goal of reduced risk of …

Author: World Health Organization

Publication date: 2015

WHO Guidance Note: Vaccine Diluents, Revision 2015

This guidance note explains the proper handling and use of vaccine diluents, including critical steps for reconstituting vaccines safely and the appropriate storage and stock management procedures. This document is designed to be used in conjunction …

Author: World Health Organization

Publication date: 2015

WHO HPV Laboratory Network

The mission of the World Health Organization (WHO) global human papillomavirus (HPV) Laboratory Network (LabNet) is to contribute to improving quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact, …

Author: World Health Organization

WHO Human Papillomavirus Vaccine Programmatic Resources

This web page provides links to further resources related to human papillomavirus vaccines. Topics include policy and decision making, implementation, and monitoring and surveillance.

Author: World Health Organization

WHO Initiative to Increase Global and Equitable Access to Influenza Vaccine in the Event of a Pandemic: Supporting Developing Country Production Capacity Through Technology Transfer

This article, published in Vaccine, showcases the interim results of the World Health Organization's technology transfer initiative to increase global and equitable access to influenza vaccine in the event of a pandemic. It highlights the progress …

Author: Friede M, Palkonyay L, Alfonso C, et al.

Publication date: 2011

WHO Policy Development Processes for a New Vaccine: Case Study of Malaria Vaccines

This article, published in Malaria Journal, analyzed the World Health Organization policy development process to predict its course for a malaria vaccine. Data needs for a malaria vaccine include safety; the demonstration of efficacy in a range of …

Author: Milstien J, Cardenas V, Cheyne J, Brooks A

Publication date: 2010

Page 92 of 94